According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
Several other equities research analysts have also issued reports on HYH. Stifel Nicolaus raised their price objective on Halyard Health from $32.00 to $37.00 and gave the company a buy rating in a research note on Tuesday, June 14th. TheStreet raised Halyard Health from a sell rating to a hold rating in a research note on Friday, July 8th. Finally, Deutsche Bank AG raised their price target on Halyard Health from $36.00 to $41.00 and gave the stock a buy rating in a research note on Wednesday, August 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of Buy and an average target price of $36.00.
Shares of Halyard Health (NYSE:HYH) opened at 34.13 on Tuesday. The stock has a 50 day moving average price of $34.94 and a 200-day moving average price of $32.85. Halyard Health has a 1-year low of $22.76 and a 1-year high of $37.31. The stock’s market capitalization is $1.59 billion.
Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.09. The business earned $400 million during the quarter, compared to analyst estimates of $383.08 million. Halyard Health had a positive return on equity of 8.91% and a negative net margin of 27.63%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the company earned $0.52 EPS. On average, analysts forecast that Halyard Health will post $1.82 earnings per share for the current year.
A number of large investors have recently modified their holdings of HYH. Victory Capital Management Inc. raised its stake in shares of Halyard Health by 46.3% in the second quarter. Victory Capital Management Inc. now owns 1,132,400 shares of the company’s stock worth $36,826,000 after buying an additional 358,150 shares during the period. EverPoint Asset Management LLC purchased a new stake in shares of Halyard Health during the second quarter worth $10,577,000. Cove Street Capital LLC raised its stake in shares of Halyard Health by 60.7% in the second quarter. Cove Street Capital LLC now owns 816,808 shares of the company’s stock worth $26,563,000 after buying an additional 308,600 shares during the period. Panagora Asset Management Inc. raised its stake in shares of Halyard Health by 291.1% in the second quarter. Panagora Asset Management Inc. now owns 379,194 shares of the company’s stock worth $12,331,000 after buying an additional 282,227 shares during the period. Finally, Chicago Equity Partners LLC purchased a new stake in shares of Halyard Health during the second quarter worth $7,189,000. 82.93% of the stock is owned by institutional investors and hedge funds.
About Halyard Health
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.